| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |